Over the past decade, stem cell research has made significant strides and has increasingly been applied as a therapeutic method for various disorders. Stem cells, by definition, are specialized cells naturally found in most body tissues, capable of self-renewal and differentiation into diverse cell types.
Various types of stem cells are under investigation for therapeutic applications, and their progress towards clinical use varies. Among these, mesenchymal stem cells, also known as mesenchymal stromal cells or medicinal signaling cells (MSCs) have been leading the way, outpacing other multipotent and pluripotent cell types. MSCs boast a diverse biological toolkit that can be harnessed for therapeutic purposes.
Corning’s new MSCulture Max media increases final hMSC yields, streamlines culture, reduces in-process risk, and eliminates media exchanges, enabling higher cell expansion with less media and fewer media changes. The MSCulture Max media consists of a basal medium and supplement with 3 versions available:
- Standard research-grade medium for MSC expansion
- Xeno-free medium optimized for rapid MSC expansion
- Xeno-free GMP-grade medium for bioproduction
The basal medium and supplement must be combined to make MSCulture Max media complete per the Instructions for Use.
